Hamid Reza Kahlaee1, Mark D Latt1,2, Carl R Schneider1. 1. The University of Sydney, Faculty of Pharmacy, Sydney, New South Wales, Australia. 2. Royal Prince Alfred Hospital, Geriatric Medicine, New South Wales, Australia.
Abstract
BACKGROUND: Evaluating effect of acute or chronic use of antihypertensives on risk of falls in older adults. METHODS: Data sources: Systematic search of primary research articles in CINAHL, Cochrane, EBM, EMBASE, and MEDLINE databases from January 1 2007 to June 1 2017. Study selection: Research studies of cohort, case-control, case-crossover, cross-sectional, or randomized controlled trial (RCT) design examining association between antihypertensives and falls in people older than 60 years were evaluated. Data synthesis: Twenty-nine studies (N = 1,234,667 participants) were included. Study quality was assessed using the Newcastle-Ottawa Scale (NOS). PRISMA and MOOSE guidelines were used for abstracting data and random-effects inverse-variance meta-analysis was conducted on 26 articles examining chronic antihypertensive use, with odds ratios (ORs) and hazards ratios (HRs) analyzed separately. Time-risk analysis was performed on 5 articles examining acute use of antihypertensives. Outcomes: Pooled ORs and HRs were calculated to determine the association between chronic antihypertensive use and falls. For time-risk analysis, OR was plotted with respect to number of days since antihypertensive commencement, change, or dose increase. RESULTS: There was no significant association between risk of falling and chronic antihypertensive medication use (OR = 0.97, 95% confidence interval [CI] 0.93-1.01, I2 = 64.1%, P = 0.000; and HR = 0.96, 95% CI 0.92-1.00, I2 = 0.0%, P = 0.706). The time-risk analysis demonstrated a significantly elevated risk of falling 0-24 hours after antihypertensive initiation, change, or dose increase. When diuretics were used, the risk remained significantly elevated till day 21. CONCLUSIONS: There is no significant association between chronic use of antihypertensives and falls in older adults. Risk of falls is highest on day zero for all antihypertensive medications.
BACKGROUND: Evaluating effect of acute or chronic use of antihypertensives on risk of falls in older adults. METHODS: Data sources: Systematic search of primary research articles in CINAHL, Cochrane, EBM, EMBASE, and MEDLINE databases from January 1 2007 to June 1 2017. Study selection: Research studies of cohort, case-control, case-crossover, cross-sectional, or randomized controlled trial (RCT) design examining association between antihypertensives and falls in people older than 60 years were evaluated. Data synthesis: Twenty-nine studies (N = 1,234,667 participants) were included. Study quality was assessed using the Newcastle-Ottawa Scale (NOS). PRISMA and MOOSE guidelines were used for abstracting data and random-effects inverse-variance meta-analysis was conducted on 26 articles examining chronic antihypertensive use, with odds ratios (ORs) and hazards ratios (HRs) analyzed separately. Time-risk analysis was performed on 5 articles examining acute use of antihypertensives. Outcomes: Pooled ORs and HRs were calculated to determine the association between chronic antihypertensive use and falls. For time-risk analysis, OR was plotted with respect to number of days since antihypertensive commencement, change, or dose increase. RESULTS: There was no significant association between risk of falling and chronic antihypertensive medication use (OR = 0.97, 95% confidence interval [CI] 0.93-1.01, I2 = 64.1%, P = 0.000; and HR = 0.96, 95% CI 0.92-1.00, I2 = 0.0%, P = 0.706). The time-risk analysis demonstrated a significantly elevated risk of falling 0-24 hours after antihypertensive initiation, change, or dose increase. When diuretics were used, the risk remained significantly elevated till day 21. CONCLUSIONS: There is no significant association between chronic use of antihypertensives and falls in older adults. Risk of falls is highest on day zero for all antihypertensive medications.
Authors: Sultana Monira Hussain; Michael E Ernst; Anna L Barker; Karen L Margolis; Christopher M Reid; Johannes T Neumann; Andrew M Tonkin; Thao Le Thi Phuong; Lawrence J Beilin; Thao Pham; Enayet K Chowdhury; Flavia M Cicuttini; Julia F M Gilmartin-Thomas; Prudence R Carr; John J McNeil Journal: Hypertension Date: 2022-06-20 Impact factor: 9.897
Authors: Stephen P Juraschek; Lawrence J Appel; Edgar R Miller; Kenneth J Mukamal; Lewis A Lipsitz Journal: Hypertension Date: 2018-10 Impact factor: 10.190
Authors: David W Goldstein; Alexandra M Hajduk; Xuemei Song; Sui Tsang; Mary Geda; James B McClurken; Mary E Tinetti; Harlan M Krumholz; Sarwat I Chaudhry Journal: J Am Geriatr Soc Date: 2021-08-12 Impact factor: 5.562
Authors: Ali Albasri; Miriam Hattle; Constantinos Koshiaris; Anna Dunnigan; Ben Paxton; Sarah Emma Fox; Margaret Smith; Lucinda Archer; Brooke Levis; Rupert A Payne; Richard D Riley; Nia Roberts; Kym I E Snell; Sarah Lay-Flurrie; Juliet Usher-Smith; Richard Stevens; F D Richard Hobbs; Richard J McManus; James P Sheppard Journal: BMJ Date: 2021-02-10